1312609-72-5 Usage
Structure
Substituted naphthalene derivative
The compound is derived from naphthalene, a fused ring system consisting of two benzene rings, with additional functional groups attached.
Bromine atom position
1
The bromine atom is attached to the first carbon atom of the naphthalene ring.
4-Methoxyphenyl group position
4
The 4-methoxyphenyl group, which consists of a phenyl ring with a methoxy group (-OCH3) attached to the fourth carbon, is attached to the fourth carbon atom of the naphthalene ring.
Use in organic synthesis
Building block for complex molecules
The compound serves as a starting material for the synthesis of more complex organic molecules.
Potential applications
Pharmaceutical and agrochemical industries
Due to its structural properties and reactivity, the compound may be used in the development of new drugs and agrochemicals.
Materials science
Studied for potential use
The compound's properties are being investigated for possible applications in materials science.
Fluorescent probe
Biological studies
The compound has been studied for its potential use as a fluorescent probe in biological research.
Ongoing research and development
Exact uses and properties
Further research is being conducted to determine the specific applications and properties of 1-bromo-4-(4-methoxyphenyl)naphthalene.
Check Digit Verification of cas no
The CAS Registry Mumber 1312609-72-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,1,2,6,0 and 9 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1312609-72:
(9*1)+(8*3)+(7*1)+(6*2)+(5*6)+(4*0)+(3*9)+(2*7)+(1*2)=125
125 % 10 = 5
So 1312609-72-5 is a valid CAS Registry Number.
1312609-72-5Relevant articles and documents
WAVELENGTH CONVERSION MATERIAL FOR HIGHLY EFFICIENT DYE-SENSITIZED SOLAR CELL, AND PREPARATION METHOD THEREOF
-
Paragraph 0236-0239, (2016/10/10)
Novel compounds represented by the present invention refers to formula 1 or formula 2, said novel compounds including wavelength change material, and including said wavelength change material relates to dye-sensitized solar cell.
NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION
-
, (2011/07/06)
The embodiments provide compounds of the general Formulae I, II, III, IV, or V as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.
